FRANKFURT (Reuters) -European pharma companies warned the European Commission president in a meeting on Tuesday that U.S. President Donald Trump's tariffs would expedite the industry's shift away from Europe and toward the United States, two industry sources told Reuters.

Pharmaceutical makers' trade lobby EFPIA called on EU President Ursula von der Leyen to push for "rapid and radical action" to mitigate the "risk of exodus" to the United States, the sources said, speaking on condition of anonymity because they were not authorised to share details on the meeting.

The EFPIA declined to comment.